Amgen
Patents, Design & Utilities
Last updated:
List of all Amgen patents 684 in total
Status | Patent |
---|---|
Application | Utility: TOTAL AFUCOSYLATED GLYCOFORMS OF ANTIBODIES PRODUCED IN CELL CULTURE Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: METHOD OF PREVENTING LAMELLAR SILICA FORMATION IN GLASS CONTAINER Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Grant | Utility: Substituted oxazines as beta-secretase inhibitors Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Application | Utility: DRUG DELIVERY DEVICE HAVING A NEEDLE GUARD MECHANISM WITH A TUNABLE THRESHOLD OF RESISTANCE TO NEEDLE GUARD MOVEMENT Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: ROTATIONALLY BIASED INSERTION MECHANISM FOR A DRUG DELIVERY PUMP Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: SYSTEMS AND APPROACHES FOR STERILIZING A DRUG DELIVERY DEVICE Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: PHARMACEUTICAL FORMULATIONS Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Grant | Utility: Purification systems and methods Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Apelin polypeptides Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Application | Utility: TREATMENT OF OVARIAN CANCER IN PATIENTS WITH ASCITES USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: MAMMALIAN CELL CULTURE Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: INJECTION DEVICE FOR DRUG DELIVERY AND PACKAGING FOR THE INJECTION DEVICE Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: ANTIBODIES WITH MODULATED GLYCAN PROFILES Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: DRUG DELIVERY MECHANISM Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Grant | Utility: Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof Filling date: 6 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Combination of epigenetic factors and bispecific compounds targeting CD33 and CD3 in the treatment of myeloid leukemia Filling date: 6 Sep 2025 Issue date: 2 Mar 2021 |
Application | Utility: TREATMENT OF ASTHMA WITH ANTI-TSLP ANTIBODY Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: PURIFICATION SYSTEMS AND METHODS Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: RAPID DISSOLUTION FORMULATION OF A CALCIUM RECEPTOR-ACTIVE COMPOUND Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: Stable Frozen Virus Formulation Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: TREM2 Antigen Binding Proteins And Uses Thereof Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS Filling date: 6 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: BI-SPECIFIC ANTI-CGRP RECEPTOR/PAC1 RECEPTOR ANTIGEN BINDING PROTEINS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: ALPHA-HYDROXY PHENYLACETIC ACID PHARMACOPHORE OR BIOISOSTERE MCL-1 PROTEIN ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: LOW PH PHARMACEUTICAL ANTIBODY FORMULATION Filling date: 6 Sep 2025 Issue date: 18 Feb 2021 |
Grant | Utility: Anti-mesothelin binding proteins Filling date: 6 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Autoinjector apparatus Filling date: 6 Sep 2025 Issue date: 16 Feb 2021 |
Application | Utility: COMPOUNDS THAT INHIBIT MCL-1 PROTEIN Filling date: 6 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: DKK1 ANTIBODIES AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS FOR THE PREPARATION OF TRYPSIN-RESISTANT POLYPEPTIDES FOR MASS SPECTROMETRIC ANALYSIS Filling date: 6 Sep 2025 Issue date: 11 Feb 2021 |
Grant | Utility: Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Method for determining whether a peptide comprises aspartate or isoaspartate Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Triazole phenyl compounds as agonists of the APJ receptor Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Application | Utility: HUMAN IL-23 ANTIGEN BINDING PROTEINS Filling date: 6 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: (+)-2-[1-(3-ETHOXY-4- METHOXYPHENYL)-2-METHYLSULFONYLETHYL]- 4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF Filling date: 6 Sep 2025 Issue date: 28 Jan 2021 |
Grant | Utility: Bisamide sarcomere activating compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Application | Utility: METHODS AND APPARATI FOR NONDESTRUCTIVE DETECTION OF UNDISSOLVED PARTICLES IN A FLUID Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: PROCESS FOR MANIPULATING THE LEVEL OF GLYCAN CONTENT OF A GLYCOPROTEIN Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: PAC1 ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: METHODS OF TREATMENT WITH PEGFILGRASTIM AND ROMIPLOSTIM Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Grant | Utility: Methods for increasing mannose content of recombinant proteins Filling date: 6 Sep 2025 Issue date: 19 Jan 2021 |
Grant | Utility: Growth differentiation factor 15 (GDF-15) constructs Filling date: 6 Sep 2025 Issue date: 19 Jan 2021 |
Application | Utility: KRAS G12C INHIBITORS AND METHODS OF USING THE SAME Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: CAMERA-BASED DRUG CONTAINER INSPECTION Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: BIOMARKERS FOR CANCER THERAPEUTICS Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use Filling date: 6 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Thiazine derivatives as .beta.-secretase inhibitors and methods of use Filling date: 6 Sep 2025 Issue date: 12 Jan 2021 |
Application | Utility: CONTROLLED DISPENSE SYRINGE Filling date: 6 Sep 2025 Issue date: 7 Jan 2021 |
Grant | Utility: Combination therapy including an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers Filling date: 6 Sep 2025 Issue date: 5 Jan 2021 |
Showing 350 to 400 of 684 patents.